Harbor Capital Advisors’s Puma Biotechnology PBYI Stock Holding History

Harbor Capital Advisors’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$21K	Buy	+2,154	New	+$19K	﹤0.01%	972

Other funds holding PBYI

OpenArc Corporate Advisory Atlanta, Georgia $8.86B AUM 19.31% 1-Year Est. Return

SummerHaven Investment Management Stamford, Connecticut $179M AUM 57.61% 1-Year Est. Return

Kathmere Capital Management Wayne, Pennsylvania $2.07B AUM 20.3% 1-Year Est. Return

C2C Wealth Management Scottsdale, Arizona $128M AUM 19.37% 1-Year Est. Return

Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Harbor Capital Advisors's PBYI Position: Q3 2026 in Review

Harbor Capital Advisors opened a new position in Puma Biotechnology (PBYI) in Q3 2026: 2,154 shares worth $21K. The stake represents ﹤0.01% of the portfolio and ranks #972 among its holdings.

24 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.

Harbor Capital Advisors held 2,154 shares of Puma Biotechnology worth $21K as of Q3 2026.
Puma Biotechnology was a new Harbor Capital Advisors position in Q3 2026.
Puma Biotechnology made up ﹤0.01% of Harbor Capital Advisors's portfolio in Q3 2026, its #972 holding.
24 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.

Based on Harbor Capital Advisors's 13F filing for Q3 2026, filed 22 Oct 2026.